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A 32 year-old white male presented to the emergency room with complaints of sudden 
onset dizziness, new syncope, and palpitations for the last 30 minutes. On arrival, his 
pulse was  approximately 250 bpm and feeble.  His blood pressure was 84/35.  He denied 
any chest pain but was short of air. 
 
His ECG is shown below: 
 
 
 
 
What is the diagnosis? 
 
(A) AV nodal Re-entrant Tachycardia 
 
(B) Ventricular Tachycardia 
 
(C) Atrial Fibrillation with accessory pathway (WPW Syndrome) 
 
(D) ECG Artifact 
 
(E) Ventricular Fibrillation 
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Correct Answer: C 
 
Atrial Fibrillation (AFib) with accessory pathway (WPW Syndrome) 
• AFib in patients with WPW Syndrome is potentially the most lethal arrhythmia 
for these patients due to its potential to deteriorate into ventricular fibrillation 
(Vfib). 
o In normal patients with an accessory pathway, the heart is protected from 
exceptionally high ventricular rates by the relatively long refractory period 
of the AV node. This generally limits the maximum ventricular rate. In 
patients with WPW, however, the accessory pathway commonly has a 
very short anterograde refractory period. This allows for much faster 
transmission of impulses from the atrial and correspondingly much higher 
ventricular rates can be reached.  
o The rapid ventricular rate may not allow for adequate diastolic filling of 
the ventricle and this in turn can predispose to hypotension. In addition, 
sympathetic discharge secondary to hypotension potentially can lead to an 
even shorter refractory period of the accessory pathway and subsequently 
increase the ventricular rate further. If the ventricular rate becomes too 
high, this can predispose to Vfib. 
o AFib usually does not conduct at a rate of more that 180 bpm through the 
normal AV node. On the other hand, conduction through an accessory 
pathway often results in more rapid ventricular rates. This usually appears 
as a bizarre, wide-complex, irregular tachycardia on ECG, with rates often 
in the 250 bpm range or higher as was noted in this patient. 
What is the best initial treatment for the patient? 
(A) IV Adenosine 
(B) IV Lidocaine 
(C) IV Diltiazem 
(D) IV Amiodarone 
(E) Cardioversion 
(F)       IV Digoxin 
(G)      IV Metoprolol 
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Correct Answer: E 
Cardioversion 
• Treatment of AFib associated with WPW is necessarily different than for a patient 
without an accessory pathway. 
o In WPW-associated AFib, the goal is to prolong the anterograde refractory 
period of the accessory pathway relative to the AV node. This slows the 
rate of conduction through the accessory pathway, thus the ventricular rate 
slows down.  
 
o In patients with non-WPW-associated AFib, the goal is to slow the 
refractory period of the AV node. 
 
o Standard rate control by drugs that prolong the refractory period of the AV 
node (e.g., calcium channel blockers, beta-blockers, digoxin, and even 
adenosine) conversely result in a higher rate of transmission through the 
accessory pathway and paradoxically increase  the ventricular rate.  This 
could have disastrous consequences possibly causing the arrhythmia to 
deteriorate into Vfib. Thus, such drugs are contraindicated in WPW-
associated AFib. Similarly, lidocaine and amiodarone typically are not 
effective in this situation either.  
 
o If the patient is unstable with evidence of hypoperfusion, primary 
synchronized cardioversion should be the first-line treatment. 
 
o If the patient is stable, medical therapy with procainamide may be tried. 
Procainamide is given with a 17 mg/kg IV infusion up to a maximum of 
50 mg/min. Procainamide is useful as it blocks conduction via the 
accessory pathway, but it has the added effect of increasing transmission 
through the AV node which occasionally  may create a conventional atrial 
fibrillation that may require treatment with other medications and/or 
cardioversion. 
 
o In this case, the patient was deemed unstable and treated with 
synchronized cardioversion.  His post-cardioversion ECG is shown below 
exhibiting the characteristic short PR interval and delta wave of WPW 
syndrome.  He subsequently was referred for EP ablation of the accessory 
pathway. 
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Post-Cardioversion ECG 
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Post-Cardioversion 
Short PR Interval Slurring of R 
Upstroke: Delta Wave 
